{"title":"一名年轻成人近期轻度Covid-19感染后出现致命性多系统炎症综合征","authors":"Mahathi Gopalakrishnan","doi":"10.47363/jmhc/2021(3)158","DOIUrl":null,"url":null,"abstract":"Corona virus disease (COVID19) has been evolving with different spectrum of illness over time. Recently, Multi system Inflammatory syndrome (MIS), a hyper inflammatory immune response has been observed after recovery from COVID, and is described in children. Here we present a young adult with Multi system inflammatory syndrome post an asymptomatic COVID infection with a rapidly worsening clinical course. Shock, gastrointestinal symptoms are described in most adults with multisystem inflammatory syndrome (MIS-A), while respiratory involvement is minimal, whereas the patient we are reporting here had severe respiratory involvement and fulminant course. As the case reports of MIS-A is being reported majority of cases are not diagnosed in time. Increased awareness about this condition is essential, as timely immunomodulatory therapy is therapeutically life saving","PeriodicalId":93468,"journal":{"name":"Journal of medicine and healthcare","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Fatal Multisystem inflammatory syndrome (MIS) in a young adult following a recent mild Covid-19\",\"authors\":\"Mahathi Gopalakrishnan\",\"doi\":\"10.47363/jmhc/2021(3)158\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Corona virus disease (COVID19) has been evolving with different spectrum of illness over time. Recently, Multi system Inflammatory syndrome (MIS), a hyper inflammatory immune response has been observed after recovery from COVID, and is described in children. Here we present a young adult with Multi system inflammatory syndrome post an asymptomatic COVID infection with a rapidly worsening clinical course. Shock, gastrointestinal symptoms are described in most adults with multisystem inflammatory syndrome (MIS-A), while respiratory involvement is minimal, whereas the patient we are reporting here had severe respiratory involvement and fulminant course. As the case reports of MIS-A is being reported majority of cases are not diagnosed in time. Increased awareness about this condition is essential, as timely immunomodulatory therapy is therapeutically life saving\",\"PeriodicalId\":93468,\"journal\":{\"name\":\"Journal of medicine and healthcare\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of medicine and healthcare\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47363/jmhc/2021(3)158\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medicine and healthcare","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47363/jmhc/2021(3)158","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Fatal Multisystem inflammatory syndrome (MIS) in a young adult following a recent mild Covid-19
Corona virus disease (COVID19) has been evolving with different spectrum of illness over time. Recently, Multi system Inflammatory syndrome (MIS), a hyper inflammatory immune response has been observed after recovery from COVID, and is described in children. Here we present a young adult with Multi system inflammatory syndrome post an asymptomatic COVID infection with a rapidly worsening clinical course. Shock, gastrointestinal symptoms are described in most adults with multisystem inflammatory syndrome (MIS-A), while respiratory involvement is minimal, whereas the patient we are reporting here had severe respiratory involvement and fulminant course. As the case reports of MIS-A is being reported majority of cases are not diagnosed in time. Increased awareness about this condition is essential, as timely immunomodulatory therapy is therapeutically life saving